Trial intelligence / Profile preview

Dose-finding study of K-877 in statin-treated patients with dyslipidemia

2013-001517-32Phase 2Completed

Sponsor
Kowa Company, Ltd.
Start
Jul 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of pemafibrate in dyslipidemia, hyperlipidemia and hypertriglyceridemia, sponsored by Kowa Company, Ltd. Started Jul 2013; status: completed.

02

Drugs

pemafibrate
03

Conditions

dyslipidemiahyperlipidemiahypertriglyceridemia

Beyond the preview

Go deeper on 2013-001517-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-001517-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call